# Senators Urge FTC to Release PBM Study

Sens. Chuck Grassley and Maria Cantwell are urging the Federal Trade Commission to complete and publicly release its Section 6(b) study of pharmacy benefit manager practices, which began in June 2022, and provide recommendations to Congress. The request is an oversight action, not a solicitation or contract announcement; any procurement effects would depend on whether the study prompts later legislative or regulatory changes to the prescription-drug market.

- Pharmacy benefit managers and organizations that procure prescription-drug services may find the eventual findings relevant to market structure and contracting assumptions.
- The signal identifies no new contract, funding, compliance requirement, or deadline, so it does not establish an immediate procurement action for agencies or contractors.

**Jurisdictions:** federal
**Industries:** Healthcare
**Published:** November 09, 2026

### Government Entities
- Federal Trade Commission (FTC)
- U.S. Congress
- U.S. Senate

### Vendors
- Express Scripts (Pharmacy benefit manager)
- Caremark (Pharmacy benefit manager)

### Sources
- [Grassley, Cantwell Urge FTC to Finish Investigation into Pharmacy Benefit Managers’ Practices, Provide Final Recommendations to Congress](https://www.grassley.senate.gov/news/news-releases/grassley-cantwell-urge-ftc-to-finish-investigation-into-pharmacy-benefit-managers-practices-provide-final-recommendations-to-congress) - Grassley Senate